Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 16Breast Neoplasms 12Glioblastoma 5Neoplasms 3Gliosarcoma 3Glioma 3Ependymoma 3Oligodendroglioma 2Neuroma, Acoustic 2Neurofibromatosis 2 2Neoplasm Metastasis 2Lung Neoplasms 2Central Nervous System Neoplasms 2Breast Neoplasms, Male 2Astrocytoma 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Recurrence 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive 1Neurilemmoma 1Medulloblastoma 1Glioma, Subependymal 1Familial ependymoma 1Esophageal Neoplasms 1Dysgerminoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

antineoplaston AS 2-1 1antineoplaston A10 1Radiosurgery 1Radiation Dose Hypofractionation 1Protons 1Proton Therapy 1Mn-PyC3A 1Lapatinib 1Hyperspectral Imaging 1HDAC-42 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurilemmoma × Lapatinib × CNS × Clear all
NCT00973739 2016-03-22

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

NYU Langone Health

Phase 2 Completed
21 enrolled 8 charts
CNS

Neurilemmoma, Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡